[Non-alcoholic fatty liver: New name, but the challenge remains].

Due to widespread diseases with increasing numbers of patients, such as metabolic syndrome, metabolic liver diseases are becoming the most common liver diseases of the future. The article explains key changes, including the nomenclature change from non-alcoholic fatty liver disease to metabolic dysfunction-associated steatotic liver disease.